To explore whether SF3A3 could be considered as a therapeutic target and provide evidence for its clinical implication in CRC, we consulted the DrugBank database with the predicted relationships between drugs and targets27, and found that SF3A3 might be a drug target of phenethyl isothiocyanate (PEITC), a naturally occurring compound found in some cruciferous vegetables, which is known to possess anti-cancer properties. This evidence concerns the gene SF3A3 and colorectal carcinoma.